Teradyne (TER) Financials

$80.98 +0.73 (+0.91%)

Closing price 04:00 PM Eastern

Extended Trading

$80.76 -0.22 (-0.27%)

As of 07:58 PM Eastern

Annual Income Statements for Teradyne

This table shows Teradyne's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	542	449	716	1,015	784	467	452	258	-43	206
Consolidated Net Income / (Loss)	542	449	716	1,015	784	467	452	258	-43	206
Net Income / (Loss) Continuing Operations	542	449	716	1,015	784	467	452	258	-43	206
Total Pre-Tax Income	609	526	840	1,161	901	526	468	524	-55	253
Total Operating Income	594	501	832	1,201	928	554	474	525	-63	243
Total Gross Profit	1,649	1,537	1,867	2,207	1,786	1,340	1,220	1,221	959	916
Total Revenue	2,820	2,676	3,155	3,703	3,121	2,295	2,101	2,137	1,753	1,640
Operating Revenue	2,820	2,676	3,155	3,703	3,121	2,295	2,101	2,137	1,753	1,640
Total Cost of Revenue	1,171	1,140	1,288	1,496	1,336	955	880	915	795	724
Operating Cost of Revenue	1,171	1,140	1,288	1,496	1,336	955	880	915	795	724
Total Operating Expenses	1,055	1,036	1,035	1,006	857	786	747	696	1,022	673
Selling, General & Admin Expense	617	577	558	548	465	437	391	349	317	306
Research & Development Expense	461	418	441	428	375	323	302	307	292	292
Amortization Expense	19	19	19	21	31	40	39	31	53	69
Other Operating Expenses / (Income)	-57	0.00	0.00	-	-	-	-	-	-	-
Restructuring Charge	16	21	17	9.31	-13	-14	15	9.36	22	5.08
Total Other Income / (Expense), net	15	25	8.45	-40	-27	-28	-6.00	-0.93	7.91	10
Interest Expense	3.59	3.81	3.72	18	24	22	22	22	3.64	1.88
Interest & Investment Income	25	27	6.38	2.63	5.98	17	20	18	9.30	7.21
Other Income / (Expense), net	-5.89	0.96	5.79	-25	-9.19	-23	-4.67	2.93	2.25	4.82
Income Tax Expense	60	77	125	146	117	58	16	267	-12	47
Other Gains / (Losses), net	-7.21	0.00	0.00	-	-	-	-	-	-	-
Basic Earnings per Share	$3.41	$2.91	$4.52	$6.15	$4.72	$2.74	$2.41	$1.30	($0.21)	$0.98
Weighted Average Basic Shares Outstanding	159.08M	154.31M	158.43M	164.96M	166.12M	170.43M	187.67M	198.07M	202.58M	211.54M
Diluted Earnings per Share	$3.32	$2.73	$4.22	$5.53	$4.28	$2.60	$2.35	$1.28	($0.21)	$0.97
Weighted Average Diluted Shares Outstanding	163.31M	164.30M	169.73M	183.63M	183.04M	179.46M	192.61M	201.64M	202.58M	213.32M
Weighted Average Basic & Diluted Shares Outstanding	161.72M	153.08M	156.05M	162.42M	166.69M	166.78M	173.63M	198.20M	206.80M	210.70M
Cash Dividends to Common per Share	$0.48	$0.44	$0.44	$0.40	$0.10	$0.09	$0.36	$0.28	$0.24	$0.24

This table shows Teradyne's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	10/2/2022
Net Income / (Loss) Attributable to Common Shareholders	99	146	146	186	64	117	128	120	84	172	183
Consolidated Net Income / (Loss)	99	146	146	186	64	117	128	120	84	172	183
Net Income / (Loss) Continuing Operations	99	146	146	186	64	117	128	120	84	172	183
Total Pre-Tax Income	119	158	159	219	73	140	144	144	97	195	226
Total Operating Income	121	154	152	210	78	124	144	140	93	167	232
Total Gross Profit	415	447	437	426	339	380	398	402	356	420	485
Total Revenue	686	753	737	730	600	671	704	684	618	732	827
Operating Revenue	686	753	737	730	600	671	704	684	618	732	827
Total Cost of Revenue	270	306	301	304	261	291	305	282	261	311	342
Operating Cost of Revenue	270	306	301	304	261	291	305	282	261	311	342
Total Operating Expenses	295	294	284	215	262	255	254	263	264	254	254
Selling, General & Admin Expense	157	156	158	154	149	142	138	146	151	143	136
Research & Development Expense	118	128	117	112	103	102	104	106	106	109	112
Amortization Expense	4.57	4.66	4.75	4.66	4.70	4.65	4.72	4.83	4.80	4.67	4.73
Restructuring Charge	15	4.55	4.58	2.01	4.43	6.03	6.86	6.36	2.04	-2.37	1.80
Total Other Income / (Expense), net	-1.78	4.21	6.92	9.04	-4.87	15	0.31	4.49	4.22	29	-5.31
Interest Expense	0.80	0.59	0.81	1.53	0.66	0.81	0.96	1.05	0.99	1.02	0.78
Interest & Investment Income	5.08	5.11	5.08	6.72	7.87	8.86	6.87	6.35	5.26	3.41	1.32
Other Income / (Expense), net	-6.06	-0.31	2.65	3.85	-12	7.43	-5.60	-0.82	-0.05	26	-5.85
Income Tax Expense	15	5.41	12	33	8.71	23	16	24	14	23	43
Other Gains / (Losses), net	-5.58	-	-1.08	-	-	-	0.00	-	-	-	-
Basic Earnings per Share	$0.61	$0.92	$0.89	$1.18	$0.42	$0.76	$0.83	$0.78	$0.54	$1.11	$1.17
Weighted Average Basic Shares Outstanding	161.50M	159.08M	163.00M	157.80M	153.05M	154.31M	153.76M	154.76M	155.90M	158.43M	156.36M
Diluted Earnings per Share	$0.61	$0.89	$0.89	$1.14	$0.40	$0.72	$0.78	$0.73	$0.50	$1.04	$1.10
Weighted Average Diluted Shares Outstanding	162.00M	163.31M	164.25M	163.47M	162.35M	164.30M	164.05M	164.75M	166.31M	169.73M	166.73M
Weighted Average Basic & Diluted Shares Outstanding	160.42M	161.72M	162.86M	163.18M	156.11M	153.08M	152.88M	154.01M	155.04M	156.05M	155.76M
Cash Dividends to Common per Share	$0.12	-	$0.12	$0.12	$0.12	-	$0.11	$0.11	$0.11	-	$0.11

This table details how cash moves in and out of Teradyne's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-204	-97	-267	208	140	-153	497	122	43	-30
Net Cash From Operating Activities	672	585	578	1,098	869	579	477	626	455	423
Net Cash From Continuing Operating Activities	672	585	578	1,098	869	579	477	626	455	423
Net Income / (Loss) Continuing Operations	542	449	716	1,015	784	467	452	258	-43	206
Consolidated Net Income / (Loss)	542	449	716	1,015	784	467	452	258	-43	206
Depreciation Expense	101	92	91	91	80	71	67	66	65	68
Amortization Expense	14	19	-5.67	34	57	50	42	35	52	90
Non-Cash Adjustments To Reconcile Net Income	37	73	89	82	56	71	49	39	380	43
Changes in Operating Assets and Liabilities, net	-22	-47	-311	-123	-108	-80	-134	228	1.93	15
Net Cash From Investing Activities	-622	-180	44	120	-570	-157	923	-263	-640	-114
Net Cash From Continuing Investing Activities	-622	-180	44	120	-570	-157	923	-263	-640	-114
Purchase of Property, Plant & Equipment	-730	-160	-163	-132	-185	-135	-114	-105	-85	-90
Purchase of Investments	-46	-162	-287	-662	-900	-663	-919	-1,392	-1,656	-1,424
Sale of Property, Plant & Equipment	0.00	0.00	3.41	0.00	0.00	-	-	-	-	-
Divestitures	90	0.00	0.00	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	62	146	491	927	515	718	2,117	1,229	1,096	1,676
Other Investing Activities, net	0.87	-4.54	0.00	0.00	0.55	2.91	9.05	5.06	5.05	6.50
Net Cash From Financing Activities	-252	-502	-893	-1,009	-158	-574	-903	-245	228	-339
Net Cash From Continuing Financing Activities	-252	-502	-893	-1,009	-158	-574	-903	-245	228	-339
Repayment of Debt	-185	-50	-67	-343	0.00	0.00	-	-	-	-2.25
Repurchase of Common Equity	-199	-397	-752	-600	-88	-500	-823	-200	-146	-300
Payment of Dividends	-76	-68	-70	-66	-66	-61	-67	-55	-49	-51
Issuance of Debt	185	0.00	0.00	-	-	-	-	-	451	-
Issuance of Common Equity	37	34	29	33	29	29	21	24	88	20
Other Financing Activities, net	-14	-21	-33	-32	-32	-42	-34	-14	-116	-5.52
Other Net Changes in Cash	-2.28	-	3.89	-	-0.66	-	-	-	-	-
Cash Interest Paid	0.77	0.30	1.50	4.24	6.44	6.00	6.21	6.45	0.45	0.30
Cash Income Taxes Paid	121	140	193	172	107	81	73	54	40	35

This table details how cash moves in and out of Teradyne's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	10/2/2022
Net Change in Cash & Equivalents	-78	43	88	-285	-50	121	24	-36	-206	144	139
Net Cash From Operating Activities	162	283	166	216	7.28	249	174	143	19	183	272
Net Cash From Continuing Operating Activities	162	283	166	216	7.28	249	174	143	19	183	272
Net Income / (Loss) Continuing Operations	99	146	146	186	64	117	128	120	84	172	183
Consolidated Net Income / (Loss)	99	146	146	186	64	117	128	120	84	172	183
Depreciation Expense	26	26	26	26	23	23	24	23	23	23	23
Amortization Expense	4.78	0.28	4.99	4.38	4.77	4.69	4.50	4.65	4.93	-21	4.92
Non-Cash Adjustments To Reconcile Net Income	33	30	9.98	-36	33	7.74	26	17	22	20	27
Changes in Operating Assets and Liabilities, net	-0.15	80	-20	36	-118	96	-8.08	-21	-114	-11	33
Net Cash From Investing Activities	-62	-67	-50	-481	-24	-30	-28	-27	-95	-1.69	100
Net Cash From Continuing Investing Activities	-62	-67	-50	-481	-24	-30	-28	-27	-95	-1.69	100
Purchase of Property, Plant & Equipment	-67	-62	-54	-569	-44	-44	-35	-39	-41	-35	-39
Acquisitions	-17	-	-	-	-	-	-	-	-	-	-
Purchase of Investments	-11	-11	-7.34	-12	-16	-24	-39	-30	-69	-20	-19
Sale and/or Maturity of Investments	33	5.63	8.62	13	35	38	51	42	15	50	158
Other Investing Activities, net	0.00	-	-	-	0.87	-	-5.00	-	0.46	-	-
Net Cash From Financing Activities	-177	-163	-29	-23	-37	-91	-128	-154	-130	-34	-232
Net Cash From Continuing Financing Activities	-177	-163	-29	-23	-37	-91	-128	-154	-130	-34	-232
Repayment of Debt	0.00	-	-	-185	0.00	-24	-9.28	-2.30	-15	-15	-9.71
Repurchase of Common Equity	-157	-144	-25	-8.19	-22	-51	-119	-135	-93	-2.08	-217
Payment of Dividends	-19	-19	-20	-19	-18	-17	-17	-17	-17	-17	-17
Issuance of Common Equity	15	0.07	15	4.90	17	0.18	17	0.60	16	-	12
Other Financing Activities, net	-15	-0.27	-0.40	-0.32	-13	-0.20	-0.28	-0.44	-20	-0.18	-0.21
Effect of Exchange Rate Changes	-0.77	-	-	-	3.24	-6.65	-	-	-0.54	-	-

This table presents Teradyne's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	3,709	3,487	3,501	3,809	3,652	2,787	2,707	3,110	2,762	2,549
Total Current Assets	1,816	2,162	2,258	2,576	2,415	1,659	1,732	2,270	1,624	1,260
Cash & Equivalents	553	758	855	1,122	914	774	927	430	308	265
Short-Term Investments	46	62	40	244	522	137	190	1,348	871	478
Accounts Receivable	471	422	491	551	498	362	291	273	192	211
Inventories, net	298	310	325	243	222	197	154	108	136	154
Prepaid Expenses	429	549	533	406	250	189	171	112	116	92
Other Current Assets	18	38	14	9.45	9.25	-	-	-	-	6.19
Other Current Nonoperating Assets	0.00	23	0.00	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	508	445	419	387	395	320	280	268	254	273
Total Noncurrent Assets	1,384	879	825	846	842	808	694	571	885	1,015
Long-Term Investments	619	117	111	134	118	104	88	126	434	266
Goodwill	395	416	403	426	454	416	382	252	223	488
Intangible Assets	16	35	53	76	101	125	125	79	100	240
Noncurrent Deferred & Refundable Income Taxes	222	176	143	102	88	75	71	84	107	7.40
Employee Benefit Assets	12	12	12	15	17	18	17	17	7.71	0.64
Other Noncurrent Operating Assets	120	112	103	93	64	68	12	12	12	13
Other Noncurrent Nonoperating Assets	0.00	12	0.00	-	-	-	-	-	-	-
Total Liabilities & Shareholders' Equity	3,709	3,487	3,501	3,809	3,652	2,787	2,707	3,110	2,762	2,549
Total Liabilities	889	961	1,050	1,245	1,442	1,307	1,184	1,156	934	583
Total Current Liabilities	625	660	746	805	701	539	476	454	373	373
Accounts Payable	135	180	140	153	134	127	101	86	95	92
Accrued Expenses	91	115	112	124	78	71	78	59	51	44
Current Deferred Revenue	108	100	148	146	135	105	78	84	84	86
Current Deferred & Payable Income Tax Liabilities	68	49	65	89	81	44	36	59	30	22
Current Employee Benefit Liabilities	205	192	212	254	220	164	149	142	110	114
Other Current Liabilities	19	18	19	20	21	19	-	-	-	-
Other Current Nonoperating Liabilities	0.00	7.38	0.00	-	-	-	-	-	-	-
Total Noncurrent Liabilities	265	301	304	440	741	768	708	702	561	210
Long-Term Debt	0.00	0.00	0.00	89	377	395	380	366	353	-
Noncurrent Deferred Revenue	65	82	104	122	133	129	117	178	23	26
Noncurrent Deferred & Payable Income Tax Liabilities	1.04	0.18	3.27	6.33	11	14	21	6.72	12	27
Noncurrent Employee Benefit Liabilities	133	132	116	151	151	134	117	120	107	104
Other Noncurrent Operating Liabilities	65	85	80	72	69	96	73	31	66	54
Other Noncurrent Nonoperating Liabilities	0.00	2.00	0.00	-	-	-	-	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,819	2,526	2,451	2,562	2,207	1,480	1,522	1,954	1,829	1,966
Total Preferred & Common Equity	2,819	2,526	2,451	2,562	2,207	1,480	1,522	1,954	1,829	1,966
Total Common Equity	2,819	2,526	2,451	2,562	2,207	1,480	1,522	1,954	1,829	1,966
Common Stock	1,930	1,846	1,775	1,832	1,786	1,741	1,694	1,663	1,619	1,506
Retained Earnings	971	707	726	737	387	-242	-158	272	230	468
Accumulated Other Comprehensive Income / (Loss)	-81	-27	-50	-5.95	34	-19	-13	19	-20	-8.14

This table presents Teradyne's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	10/2/2022
Total Assets	3,706	3,709	3,770	3,632	3,411	3,487	3,371	3,395	3,383	3,501	3,320
Total Current Assets	1,756	1,816	1,839	1,756	2,065	2,162	2,099	2,124	2,112	2,258	2,128
Cash & Equivalents	476	553	510	422	707	758	637	613	649	855	711
Short-Term Investments	32	46	42	39	41	62	80	95	93	40	65
Accounts Receivable	460	471	484	470	426	422	456	493	455	491	530
Inventories, net	345	298	297	289	314	310	323	347	352	325	311
Prepaid Expenses	424	429	490	516	538	549	593	561	549	533	503
Other Current Assets	19	18	16	21	16	38	11	14	13	14	7.72
Plant, Property, & Equipment, net	542	508	492	472	457	445	436	437	432	419	415
Total Noncurrent Assets	1,409	1,384	1,439	1,403	888	879	835	834	839	825	777
Long-Term Investments	623	619	664	648	122	117	104	105	117	111	111
Goodwill	409	395	419	405	408	416	401	412	410	403	376
Intangible Assets	18	16	21	25	30	35	39	45	49	53	56
Noncurrent Deferred & Refundable Income Taxes	231	222	202	193	186	176	163	152	149	143	130
Employee Benefit Assets	12	12	13	11	11	12	11	12	12	12	14
Other Noncurrent Operating Assets	115	120	119	120	120	112	117	109	103	103	91
Total Liabilities & Shareholders' Equity	3,706	3,709	3,770	3,632	3,411	3,487	3,371	3,395	3,383	3,501	3,320
Total Liabilities	908	889	867	901	853	961	929	960	934	1,050	1,066
Total Current Liabilities	649	625	595	626	554	660	641	670	628	746	702
Accounts Payable	187	135	158	161	154	180	176	153	142	140	168
Accrued Expenses	100	91	105	109	101	115	123	114	115	112	126
Current Deferred Revenue	120	108	100	103	100	100	109	120	119	148	144
Current Deferred & Payable Income Tax Liabilities	81	68	53	74	56	49	36	65	77	65	64
Current Employee Benefit Liabilities	143	205	160	161	121	192	155	164	119	212	168
Other Current Liabilities	18	19	19	18	17	18	18	20	20	19	17
Total Noncurrent Liabilities	259	265	272	275	299	301	289	290	306	304	364
Noncurrent Deferred Revenue	64	65	66	61	79	82	79	83	101	104	108
Noncurrent Deferred & Payable Income Tax Liabilities	0.87	1.04	0.16	0.10	0.13	0.18	0.24	1.30	2.33	3.27	1.33
Noncurrent Employee Benefit Liabilities	136	133	138	135	135	132	123	124	121	116	137
Other Noncurrent Operating Liabilities	58	65	69	79	82	85	86	82	81	80	67
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,797	2,819	2,903	2,731	2,558	2,526	2,441	2,435	2,449	2,451	2,254
Total Preferred & Common Equity	2,797	2,819	2,903	2,731	2,558	2,526	2,441	2,435	2,449	2,451	2,254
Total Common Equity	2,797	2,819	2,903	2,731	2,558	2,526	2,441	2,435	2,449	2,451	2,254
Common Stock	1,946	1,930	1,917	1,886	1,867	1,846	1,835	1,804	1,792	1,775	1,766
Retained Earnings	893	971	990	889	730	707	654	661	694	726	573
Accumulated Other Comprehensive Income / (Loss)	-42	-81	-4.03	-44	-40	-27	-48	-30	-36	-50	-85

This table displays calculated financial ratios and metrics derived from Teradyne's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.36%	-15.17%	-14.79%	18.63%	36.01%	9.24%	-1.68%	21.87%	6.93%	-0.50%
EBITDA Growth	14.74%	-33.58%	-29.10%	23.23%	62.08%	12.54%	-8.05%	1,022.76%	-86.20%	37.65%
EBIT Growth	17.10%	-40.07%	-28.77%	27.95%	73.11%	13.19%	-11.20%	970.02%	-124.50%	157.97%
NOPAT Growth	25.23%	-39.60%	-32.50%	29.87%	64.14%	7.58%	77.25%	685.65%	-122.24%	141.22%
Net Income Growth	20.86%	-37.28%	-29.48%	29.39%	67.74%	3.47%	75.32%	693.47%	-121.03%	154.06%
EPS Growth	21.61%	-35.31%	-23.69%	29.21%	64.62%	10.64%	83.59%	709.52%	-121.65%	162.16%
Operating Cash Flow Growth	14.86%	1.26%	-47.38%	26.40%	50.14%	21.36%	-23.88%	37.63%	7.59%	-14.02%
Free Cash Flow Firm Growth	38.08%	-6.10%	-59.30%	54.80%	70.95%	115.72%	-57.32%	7.83%	5,621.09%	-97.70%
Invested Capital Growth	2.41%	4.48%	27.66%	9.90%	22.84%	18.51%	66.36%	-22.69%	-41.45%	24.57%
Revenue Q/Q Growth	3.01%	-2.24%	-4.63%	3.52%	3.46%	6.25%	1.95%	4.88%	3.64%	-0.29%
EBITDA Q/Q Growth	2.98%	-9.04%	-9.13%	1.52%	8.78%	7.26%	3.48%	6.55%	193.57%	26.92%
EBIT Q/Q Growth	3.80%	-10.85%	-7.12%	2.49%	9.19%	7.96%	3.30%	8.10%	52.65%	88.77%
NOPAT Q/Q Growth	9.09%	-9.23%	-9.83%	1.85%	8.23%	-0.03%	125.75%	-40.17%	51.16%	107.95%
Net Income Q/Q Growth	5.69%	-10.96%	-6.74%	2.81%	10.00%	-3.85%	123.58%	-40.07%	60.67%	99.87%
EPS Q/Q Growth	5.40%	-10.49%	-5.17%	4.14%	9.46%	-3.35%	123.81%	-40.47%	61.82%	97.96%
Operating Cash Flow Q/Q Growth	5.29%	12.58%	-20.37%	6.90%	5.35%	5.46%	8.88%	21.35%	-2.83%	-22.73%
Free Cash Flow Firm Q/Q Growth	10.95%	39.42%	-34.84%	10.65%	15.50%	-12.56%	77.30%	23.13%	2.88%	-95.36%
Invested Capital Q/Q Growth	-5.07%	-4.93%	4.50%	-5.16%	0.76%	3.38%	-3.00%	-31.81%	7.68%	0.47%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.48%	57.42%	59.18%	59.59%	57.21%	58.38%	58.09%	57.17%	54.68%	55.85%
EBITDA Margin	24.94%	22.90%	29.25%	35.15%	33.84%	28.40%	27.56%	29.47%	3.20%	24.78%
Operating Margin	21.06%	18.72%	26.37%	32.43%	29.74%	24.12%	22.55%	24.59%	-3.59%	14.82%
EBIT Margin	20.85%	18.76%	26.55%	31.76%	29.45%	23.14%	22.33%	24.72%	-3.46%	15.11%
Profit (Net Income) Margin	19.23%	16.77%	22.68%	27.40%	25.12%	20.37%	21.51%	12.06%	-2.48%	12.59%
Tax Burden Percent	89.05%	85.38%	85.14%	87.39%	87.03%	88.91%	96.58%	49.14%	78.86%	81.57%
Interest Burden Percent	103.60%	104.69%	100.32%	98.71%	98.02%	99.01%	99.72%	99.27%	90.68%	102.15%
Effective Tax Rate	9.77%	14.62%	14.86%	12.61%	12.97%	11.09%	3.43%	50.86%	0.00%	18.43%
Return on Invested Capital (ROIC)	33.86%	27.97%	53.09%	93.75%	83.52%	61.50%	78.02%	51.12%	-5.72%	22.60%
ROIC Less NNEP Spread (ROIC-NNEP)	33.26%	25.78%	52.48%	96.49%	86.24%	65.04%	78.52%	51.15%	-5.77%	21.88%
Return on Net Nonoperating Assets (RNNOA)	-13.57%	-9.93%	-24.56%	-51.25%	-41.03%	-30.36%	-52.02%	-37.49%	3.43%	-12.39%
Return on Equity (ROE)	20.29%	18.03%	28.53%	42.50%	42.49%	31.14%	25.99%	13.63%	-2.29%	10.21%
Cash Return on Invested Capital (CROIC)	31.48%	23.58%	28.79%	84.32%	63.02%	44.56%	28.19%	76.71%	46.58%	0.72%
Operating Return on Assets (OROA)	16.34%	14.37%	22.92%	31.52%	28.55%	19.33%	16.13%	17.99%	-2.29%	9.74%
Return on Assets (ROA)	15.08%	12.84%	19.57%	27.19%	24.35%	17.02%	15.54%	8.78%	-1.64%	8.12%
Return on Common Equity (ROCE)	20.29%	18.03%	28.52%	42.45%	42.45%	31.14%	25.99%	13.63%	-2.29%	10.21%
Return on Equity Simple (ROE_SIMPLE)	19.24%	17.77%	29.19%	39.59%	35.53%	31.58%	29.68%	13.19%	-2.37%	10.50%
Net Operating Profit after Tax (NOPAT)	536	428	708	1,049	808	492	458	258	-44	198
NOPAT Margin	19.00%	15.99%	22.45%	28.34%	25.88%	21.45%	21.78%	12.08%	-2.51%	12.09%
Net Nonoperating Expense Percent (NNEP)	0.60%	2.18%	0.61%	-2.74%	-2.71%	-3.54%	-0.50%	-0.03%	0.06%	0.72%
Return On Investment Capital (ROIC_SIMPLE)	19.00%	16.94%	28.32%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	41.52%	42.58%	40.82%	40.41%	42.79%	41.62%	41.91%	42.83%	45.32%	44.15%
SG&A Expenses to Revenue	21.88%	21.57%	17.69%	14.79%	14.89%	19.05%	18.60%	16.33%	18.05%	18.68%
R&D to Revenue	16.34%	15.62%	13.96%	11.55%	12.01%	14.07%	14.35%	14.38%	16.66%	17.82%
Operating Expenses to Revenue	37.42%	38.70%	32.81%	27.17%	27.47%	34.26%	35.54%	32.58%	58.27%	41.03%
Earnings before Interest and Taxes (EBIT)	588	502	838	1,176	919	531	469	528	-61	248
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	703	613	923	1,302	1,056	652	579	630	56	406
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.27	6.53	5.50	10.29	8.90	7.58	3.60	4.06	2.68	2.05
Price to Tangible Book Value (P/TBV)	8.51	7.95	6.76	12.80	11.88	11.95	5.40	4.89	3.25	3.25
Price to Revenue (P/Rev)	7.26	6.17	4.27	7.12	6.29	4.89	2.61	3.71	2.79	2.45
Price to Earnings (P/E)	37.77	36.78	18.83	25.99	25.04	23.99	12.13	30.76	0.00	19.47
Dividend Yield	0.38%	0.41%	0.51%	0.25%	0.34%	0.54%	1.18%	0.69%	0.99%	1.23%
Earnings Yield	2.65%	2.72%	5.31%	3.85%	3.99%	4.17%	8.25%	3.25%	0.00%	5.13%
Enterprise Value to Invested Capital (EV/IC)	12.03	9.96	8.37	21.31	17.34	12.21	6.40	14.56	6.38	3.11
Enterprise Value to Revenue (EV/Rev)	6.83	5.82	3.97	6.75	5.93	4.62	2.23	3.00	2.07	1.85
Enterprise Value to EBITDA (EV/EBITDA)	27.40	25.40	13.57	19.19	17.51	16.27	8.10	10.19	64.81	7.45
Enterprise Value to EBIT (EV/EBIT)	32.77	31.01	14.95	21.24	20.12	19.96	9.99	12.14	0.00	12.22
Enterprise Value to NOPAT (EV/NOPAT)	35.96	36.39	17.68	23.80	22.89	21.53	10.25	24.85	0.00	15.28
Enterprise Value to Operating Cash Flow (EV/OCF)	28.66	26.60	21.67	22.74	21.28	18.32	9.83	10.24	7.99	7.16
Enterprise Value to Free Cash Flow (EV/FCFF)	38.68	43.16	32.59	26.47	30.34	29.72	28.36	16.56	10.12	482.24
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.02	0.04	0.19	0.27	0.27	0.20	0.19	0.01
Long-Term Debt to Equity	0.00	0.00	0.00	0.03	0.17	0.27	0.25	0.19	0.19	0.00
Financial Leverage	-0.41	-0.39	-0.47	-0.53	-0.48	-0.47	-0.66	-0.73	-0.59	-0.57
Leverage Ratio	1.35	1.40	1.46	1.56	1.74	1.83	1.67	1.55	1.40	1.26
Compound Leverage Factor	1.39	1.47	1.46	1.54	1.71	1.81	1.67	1.54	1.27	1.28
Debt to Total Capital	0.00%	0.00%	2.00%	4.06%	15.65%	21.43%	21.41%	16.66%	16.21%	0.78%
Short-Term Debt to Total Capital	0.00%	0.00%	2.00%	0.72%	1.27%	0.48%	1.80%	1.05%	0.05%	0.78%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	3.34%	14.38%	20.95%	19.62%	15.61%	16.16%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.06%	0.14%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	98.00%	95.89%	84.21%	78.57%	78.59%	83.34%	83.79%	99.22%
Debt to EBITDA	0.00	0.00	0.05	0.08	0.39	0.62	0.72	0.62	6.31	0.04
Net Debt to EBITDA	0.00	0.00	-1.03	-1.07	-1.08	-0.94	-1.36	-2.40	-22.45	-2.44
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.07	0.36	0.61	0.66	0.58	6.29	0.00
Debt to NOPAT	0.00	0.00	0.07	0.10	0.51	0.82	0.91	1.51	-8.02	0.08
Net Debt to NOPAT	0.00	0.00	-1.35	-1.33	-1.42	-1.24	-1.73	-5.86	28.56	-5.01
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.09	0.47	0.80	0.83	1.42	-8.00	0.00
Altman Z-Score	15.86	12.35	10.20	15.52	10.57	6.96	4.60	6.19	4.37	5.78
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.03%	0.11%	0.10%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.91	3.28	3.03	3.20	3.45	3.08	3.64	5.00	4.36	3.38
Quick Ratio	1.71	1.88	1.86	2.38	2.76	2.36	2.96	4.51	3.68	2.56
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	498	361	384	944	610	357	165	387	359	6.28
Operating Cash Flow to CapEx	92.06%	366.59%	361.57%	829.13%	469.75%	429.84%	416.93%	594.54%	533.82%	470.72%
Free Cash Flow to Firm to Interest Expense	138.86	94.78	103.30	52.96	25.21	16.05	7.59	17.88	98.78	3.35
Operating Cash Flow to Interest Expense	187.39	153.77	155.40	61.64	35.93	26.04	21.90	28.92	125.16	225.52
Operating Cash Flow Less CapEx to Interest Expense	-16.16	111.82	112.42	54.20	28.28	19.98	16.64	24.06	101.71	177.61
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.78	0.77	0.86	0.99	0.97	0.84	0.72	0.73	0.66	0.64
Accounts Receivable Turnover	6.31	5.86	6.06	7.06	7.26	7.02	7.45	9.19	8.69	9.05
Inventory Turnover	3.85	3.59	4.53	6.43	6.38	5.45	6.74	7.52	5.49	5.60
Fixed Asset Turnover	5.91	6.19	7.83	9.47	8.73	7.65	7.66	8.18	6.65	5.44
Accounts Payable Turnover	7.44	7.13	8.80	10.43	10.26	8.40	9.41	10.07	8.47	10.33
Days Sales Outstanding (DSO)	57.83	62.28	60.27	51.66	50.27	51.98	49.00	39.74	42.03	40.33
Days Inventory Outstanding (DIO)	94.83	101.69	80.54	56.78	57.23	66.92	54.12	48.56	66.50	65.22
Days Payable Outstanding (DPO)	49.08	51.22	41.50	34.98	35.56	43.43	38.78	36.25	43.11	35.32
Cash Conversion Cycle (CCC)	103.58	112.75	99.31	73.46	71.94	75.47	64.34	52.05	65.41	70.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,601	1,563	1,496	1,172	1,067	868	733	440	570	973
Invested Capital Turnover	1.78	1.75	2.36	3.31	3.23	2.87	3.58	4.23	2.27	1.87
Increase / (Decrease) in Invested Capital	38	67	324	106	198	136	292	-129	-403	192
Enterprise Value (EV)	19,267	15,568	12,521	24,979	18,495	10,601	4,688	6,414	3,635	3,028
Market Capitalization	20,486	16,505	13,476	26,369	19,636	11,212	5,478	7,927	4,894	4,021
Book Value per Share	$17.31	$16.52	$15.74	$15.72	$13.29	$8.83	$8.49	$9.96	$9.09	$9.57
Tangible Book Value per Share	$14.79	$13.57	$12.81	$12.64	$9.95	$5.60	$5.66	$8.27	$7.48	$6.02
Total Capital	2,819	2,526	2,501	2,672	2,621	1,884	1,937	2,344	2,182	1,981
Total Debt	0.00	0.00	50	108	410	404	415	390	354	16
Total Long-Term Debt	0.00	0.00	0.00	89	377	395	380	366	353	0.00
Net Debt	-1,218	-937	-955	-1,392	-1,144	-612	-790	-1,513	-1,259	-993
Capital Expenditures (CapEx)	730	160	160	132	185	135	114	105	85	90
Debt-free, Cash-free Net Working Capital (DFCFNWC)	592	682	667	424	312	218	174	63	73	160
Debt-free Net Working Capital (DFNWC)	1,192	1,502	1,562	1,790	1,748	1,129	1,291	1,840	1,252	903
Net Working Capital (NWC)	1,192	1,502	1,512	1,771	1,715	1,120	1,256	1,816	1,251	887
Net Nonoperating Expense (NNE)	-6.59	-21	-7.19	35	24	25	5.79	0.46	-0.66	-8.28
Net Nonoperating Obligations (NNO)	-1,218	-963	-955	-1,392	-1,144	-612	-790	-1,513	-1,259	-993
Total Depreciation and Amortization (D&A)	115	111	85	125	137	121	110	101	117	159
Debt-free, Cash-free Net Working Capital to Revenue	21.00%	25.50%	21.15%	11.45%	9.98%	9.49%	8.29%	2.93%	4.18%	9.77%
Debt-free Net Working Capital to Revenue	42.26%	56.13%	49.50%	48.35%	56.00%	49.19%	61.46%	86.14%	71.42%	55.05%
Net Working Capital to Revenue	42.26%	56.13%	47.91%	47.83%	54.93%	48.80%	59.80%	84.99%	71.36%	54.11%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.41	$2.91	$4.52	$6.15	$4.72	$2.74	$2.41	$1.30	($0.21)	$0.98
Adjusted Weighted Average Basic Shares Outstanding	159.08M	154.31M	158.43M	164.96M	166.12M	170.43M	187.67M	198.07M	202.58M	211.54M
Adjusted Diluted Earnings per Share	$3.32	$2.73	$4.22	$5.53	$4.28	$2.60	$2.35	$1.28	($0.21)	$0.97
Adjusted Weighted Average Diluted Shares Outstanding	163.31M	164.30M	169.73M	183.63M	183.04M	179.46M	192.61M	201.64M	202.58M	213.32M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$2.74	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	161.72M	153.08M	156.05M	162.42M	166.69M	166.78M	173.63M	195.42M	200.30M	204.34M
Normalized Net Operating Profit after Tax (NOPAT)	550	446	723	1,057	796	480	472	374	208	202
Normalized NOPAT Margin	19.50%	16.66%	22.91%	28.56%	25.52%	20.91%	22.48%	17.52%	11.87%	12.34%
Pre Tax Income Margin	21.60%	19.64%	26.64%	31.35%	28.87%	22.91%	22.27%	24.54%	-3.14%	15.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	163.90	131.90	225.26	66.00	38.01	23.89	21.54	24.39	-16.69	132.08
NOPAT to Interest Expense	149.37	112.41	190.46	58.89	33.41	22.15	21.01	11.92	-12.12	105.65
EBIT Less CapEx to Interest Expense	-39.66	89.96	182.28	58.57	30.36	17.84	16.29	19.52	-40.14	84.17
NOPAT Less CapEx to Interest Expense	-54.19	70.46	147.48	51.45	25.76	16.09	15.76	7.05	-35.57	57.74
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	14.09%	15.13%	9.74%	6.50%	8.48%	13.11%	14.90%	21.52%	-111.97%	24.56%
Augmented Payout Ratio	50.70%	103.65%	114.86%	65.64%	19.76%	120.07%	197.18%	99.25%	-448.98%	169.83%

This table displays calculated financial ratios and metrics derived from Teradyne's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	10/2/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.31%	12.27%	4.77%	6.64%	-2.87%	-8.37%	-14.91%	-18.59%	-18.25%	-17.31%	-12.99%
EBITDA Growth	54.61%	12.74%	11.26%	46.83%	-22.09%	-18.11%	-34.45%	-37.33%	-42.22%	-32.21%	-23.31%
EBIT Growth	74.66%	16.33%	11.81%	54.01%	-29.22%	-31.68%	-38.68%	-41.69%	-48.63%	-24.99%	-25.01%
NOPAT Growth	54.84%	42.49%	9.77%	53.55%	-14.29%	-29.20%	-31.92%	-43.42%	-52.12%	-34.70%	-32.44%
Net Income Growth	54.05%	24.94%	13.69%	55.16%	-23.15%	-32.06%	-30.18%	-39.30%	-48.41%	-23.09%	-28.53%
EPS Growth	52.50%	23.61%	14.10%	56.16%	-20.00%	-30.77%	-29.09%	-37.07%	-45.65%	-18.11%	-21.99%
Operating Cash Flow Growth	2,120.59%	13.58%	-4.63%	51.34%	-62.36%	35.65%	-35.81%	23.66%	159.13%	-44.64%	-48.03%
Free Cash Flow Firm Growth	192.67%	199.01%	215.84%	456.40%	119.13%	120.89%	-937.43%	-132.79%	-362.25%	-248.13%	-108.12%
Invested Capital Growth	0.38%	2.41%	2.57%	-1.94%	2.12%	4.48%	14.85%	11.86%	18.86%	27.66%	15.86%
Revenue Q/Q Growth	-8.93%	2.11%	1.02%	21.68%	-10.55%	-4.71%	2.82%	10.83%	-15.62%	-11.51%	-1.63%
EBITDA Q/Q Growth	-19.44%	-2.81%	-24.13%	160.27%	-41.25%	-4.08%	0.12%	38.10%	-45.41%	-23.22%	-4.28%
EBIT Q/Q Growth	-25.14%	-0.93%	-27.78%	226.07%	-50.14%	-4.78%	-0.52%	49.86%	-51.87%	-14.54%	-5.41%
NOPAT Q/Q Growth	-28.51%	5.69%	-21.42%	160.79%	-34.21%	-18.58%	9.91%	45.57%	-45.65%	-21.71%	-8.65%
Net Income Q/Q Growth	-32.38%	0.41%	-21.81%	190.16%	-45.16%	-8.63%	6.72%	43.72%	-51.52%	-6.10%	-7.23%
EPS Q/Q Growth	-31.46%	0.00%	-21.93%	185.00%	-44.44%	-7.69%	6.85%	46.00%	-51.92%	-5.45%	-5.17%
Operating Cash Flow Q/Q Growth	-42.79%	69.94%	-23.05%	2,868.39%	-97.07%	42.69%	22.12%	638.35%	-89.46%	-32.47%	135.25%
Free Cash Flow Firm Q/Q Growth	-9.93%	12.73%	-53.43%	518.83%	-7.97%	143.68%	-43.29%	66.78%	-0.47%	-2,069.01%	-104.53%
Invested Capital Q/Q Growth	4.08%	-5.07%	3.95%	-2.26%	6.18%	-4.93%	-0.62%	1.79%	8.64%	4.50%	-3.20%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.57%	59.41%	59.20%	58.34%	56.56%	56.60%	56.60%	58.81%	57.72%	57.45%	58.69%
EBITDA Margin	21.15%	23.91%	25.13%	33.45%	15.64%	23.81%	23.66%	24.30%	19.50%	26.65%	30.71%
Operating Margin	17.62%	20.40%	20.62%	28.82%	12.97%	18.54%	20.46%	20.44%	15.04%	22.76%	27.99%
EBIT Margin	16.73%	20.36%	20.98%	29.35%	10.95%	19.65%	19.66%	20.32%	15.03%	26.35%	27.28%
Profit (Net Income) Margin	14.42%	19.43%	19.75%	25.52%	10.70%	17.46%	18.21%	17.54%	13.53%	23.54%	22.18%
Tax Burden Percent	83.09%	92.68%	91.61%	84.90%	88.06%	83.73%	88.80%	83.14%	86.04%	88.25%	81.12%
Interest Burden Percent	103.73%	102.95%	102.76%	102.42%	110.97%	106.11%	104.27%	103.82%	104.60%	101.24%	100.24%
Effective Tax Rate	12.22%	3.43%	7.71%	15.10%	11.94%	16.27%	11.20%	16.86%	13.96%	11.75%	18.88%
Return on Invested Capital (ROIC)	27.02%	35.11%	31.29%	40.38%	18.48%	27.16%	32.33%	31.03%	26.09%	47.51%	56.32%
ROIC Less NNEP Spread (ROIC-NNEP)	27.72%	35.30%	30.76%	39.57%	18.98%	25.80%	32.30%	30.56%	25.71%	45.35%	56.72%
Return on Net Nonoperating Assets (RNNOA)	-10.50%	-14.40%	-11.59%	-14.47%	-6.53%	-9.94%	-11.14%	-10.33%	-10.08%	-21.22%	-25.16%
Return on Equity (ROE)	16.52%	20.71%	19.70%	25.92%	11.95%	17.21%	21.19%	20.70%	16.00%	26.28%	31.15%
Cash Return on Invested Capital (CROIC)	34.09%	31.48%	26.96%	31.16%	23.24%	23.58%	16.82%	22.78%	24.32%	28.79%	44.20%
Operating Return on Assets (OROA)	13.67%	15.96%	16.09%	22.59%	8.57%	15.05%	16.09%	16.89%	12.97%	22.74%	25.49%
Return on Assets (ROA)	11.78%	15.23%	15.15%	19.64%	8.38%	13.37%	14.90%	14.58%	11.67%	20.32%	20.73%
Return on Common Equity (ROCE)	16.52%	20.71%	19.70%	25.92%	11.95%	17.21%	21.19%	20.70%	16.00%	26.28%	31.14%
Return on Equity Simple (ROE_SIMPLE)	20.63%	0.00%	17.68%	18.15%	16.79%	0.00%	20.64%	22.97%	26.01%	0.00%	34.04%
Net Operating Profit after Tax (NOPAT)	106	148	140	179	68	104	128	116	80	147	188
NOPAT Margin	15.47%	19.70%	19.03%	24.47%	11.42%	15.52%	18.17%	16.99%	12.94%	20.09%	22.71%
Net Nonoperating Expense Percent (NNEP)	-0.70%	-0.19%	0.53%	0.81%	-0.50%	1.35%	0.03%	0.47%	0.38%	2.15%	-0.41%
Return On Investment Capital (ROIC_SIMPLE)	3.79%	5.26%	-	-	-	4.12%	-	-	-	5.88%	-
Cost of Revenue to Revenue	39.43%	40.59%	40.80%	41.66%	43.44%	43.40%	43.40%	41.19%	42.28%	42.55%	41.31%
SG&A Expenses to Revenue	22.93%	20.69%	21.38%	21.16%	24.87%	21.23%	19.66%	21.29%	24.45%	19.51%	16.40%
R&D to Revenue	17.24%	17.05%	15.93%	15.32%	17.21%	15.24%	14.84%	15.44%	17.13%	14.87%	13.51%
Operating Expenses to Revenue	42.95%	39.01%	38.58%	29.52%	43.60%	38.06%	36.14%	38.37%	42.68%	34.69%	30.70%
Earnings before Interest and Taxes (EBIT)	115	153	155	214	66	132	138	139	93	193	226
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	145	180	185	244	94	160	167	166	120	195	254
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.79	7.27	7.57	8.48	6.74	6.53	6.31	7.06	6.81	5.50	5.19
Price to Tangible Book Value (P/TBV)	5.65	8.51	8.92	10.06	8.13	7.95	7.70	8.69	8.38	6.76	6.42
Price to Revenue (P/Rev)	4.61	7.26	8.03	8.56	6.48	6.17	5.63	6.01	5.53	4.27	3.53
Price to Earnings (P/E)	23.20	37.77	42.81	46.71	40.13	36.78	30.57	30.73	26.19	18.83	15.24
Dividend Yield	0.58%	0.38%	0.35%	0.31%	0.40%	0.41%	0.44%	0.40%	0.41%	0.51%	0.58%
Earnings Yield	4.31%	2.65%	2.34%	2.14%	2.49%	2.72%	3.27%	3.25%	3.82%	5.31%	6.56%
Enterprise Value to Invested Capital (EV/IC)	7.36	12.03	12.31	13.59	9.86	9.96	8.89	9.92	9.76	8.37	7.59
Enterprise Value to Revenue (EV/Rev)	4.22	6.83	7.58	8.15	6.16	5.82	5.34	5.73	5.26	3.97	3.29
Enterprise Value to EBITDA (EV/EBITDA)	16.24	27.40	30.39	33.19	27.91	25.40	21.68	21.55	18.44	13.57	10.71
Enterprise Value to EBIT (EV/EBIT)	19.24	32.77	36.64	40.07	34.46	31.01	25.95	25.23	21.15	14.95	12.05
Enterprise Value to NOPAT (EV/NOPAT)	21.38	35.96	42.26	46.07	39.32	36.39	31.00	30.82	25.51	17.68	13.84
Enterprise Value to Operating Cash Flow (EV/OCF)	14.83	28.66	32.51	34.09	28.55	26.60	28.11	26.59	26.90	21.67	14.98
Enterprise Value to Free Cash Flow (EV/FCFF)	21.62	38.68	46.23	43.17	42.86	43.16	56.47	45.97	43.59	32.59	18.44
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.02	0.03
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02
Financial Leverage	-0.38	-0.41	-0.38	-0.37	-0.34	-0.39	-0.34	-0.34	-0.39	-0.47	-0.44
Leverage Ratio	1.33	1.35	1.34	1.36	1.36	1.40	1.42	1.45	1.42	1.46	1.48
Compound Leverage Factor	1.38	1.39	1.37	1.39	1.51	1.49	1.49	1.51	1.49	1.48	1.48
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.95%	1.33%	1.41%	2.00%	2.79%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.95%	1.33%	1.41%	2.00%	0.63%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.16%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	99.05%	98.67%	98.59%	98.00%	97.21%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.04	0.04	0.05	0.06
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-1.18	-1.02	-0.96	-1.03	-0.81
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.05
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.05	0.06	0.06	0.07	0.08
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-1.69	-1.47	-1.33	-1.35	-1.05
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06
Altman Z-Score	10.42	15.47	16.83	17.07	13.80	12.00	11.69	12.51	12.52	9.59	8.56
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.06%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.70	2.91	3.09	2.80	3.73	3.28	3.28	3.17	3.36	3.03	3.03
Quick Ratio	1.49	1.71	1.74	1.49	2.12	1.88	1.83	1.79	1.91	1.86	1.86
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	100	111	98	211	34	37	-85	-59	-178	-177	-8.17
Operating Cash Flow to CapEx	241.13%	452.92%	306.50%	37.94%	16.53%	561.12%	503.83%	363.67%	46.66%	530.42%	697.69%
Free Cash Flow to Firm to Interest Expense	125.36	188.17	121.47	137.73	51.52	45.63	-87.98	-56.58	-180.32	-174.52	-10.48
Operating Cash Flow to Interest Expense	203.32	480.54	205.78	141.22	11.01	306.76	181.05	136.62	19.59	180.69	348.66
Operating Cash Flow Less CapEx to Interest Expense	119.00	374.44	138.64	-231.00	-55.59	252.09	145.11	99.05	-22.40	146.63	298.68
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.82	0.78	0.77	0.77	0.78	0.77	0.82	0.83	0.86	0.86	0.93
Accounts Receivable Turnover	6.55	6.31	5.82	5.61	6.03	5.86	5.55	4.86	6.02	6.06	5.87
Inventory Turnover	3.58	3.85	3.73	3.65	3.42	3.59	3.66	3.72	4.08	4.53	4.99
Fixed Asset Turnover	5.82	5.91	5.90	5.95	5.98	6.19	6.43	6.74	7.25	7.83	8.21
Accounts Payable Turnover	6.93	7.44	6.91	7.40	7.69	7.13	6.74	7.28	8.36	8.80	8.27
Days Sales Outstanding (DSO)	55.69	57.83	62.68	65.03	60.52	62.28	65.75	75.08	60.62	60.27	62.20
Days Inventory Outstanding (DIO)	101.90	94.83	97.84	99.98	106.76	101.69	99.66	98.09	89.37	80.54	73.16
Days Payable Outstanding (DPO)	52.69	49.08	52.80	49.35	47.47	51.22	54.14	50.16	43.69	41.50	44.16
Cash Conversion Cycle (CCC)	104.90	103.58	107.72	115.66	119.81	112.75	111.27	123.01	106.30	99.31	91.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,666	1,601	1,687	1,622	1,660	1,563	1,644	1,655	1,626	1,496	1,432
Invested Capital Turnover	1.75	1.78	1.64	1.65	1.62	1.75	1.78	1.83	2.02	2.36	2.48
Increase / (Decrease) in Invested Capital	6.38	38	42	-32	34	67	213	175	258	324	196
Enterprise Value (EV)	12,256	19,267	20,754	22,041	16,364	15,568	14,611	16,407	15,863	12,521	10,871
Market Capitalization	13,387	20,486	21,970	23,150	17,234	16,505	15,408	17,187	16,687	13,476	11,693
Book Value per Share	$17.30	$17.31	$17.79	$17.49	$16.71	$16.52	$15.85	$15.71	$15.70	$15.74	$14.38
Tangible Book Value per Share	$14.66	$14.79	$15.09	$14.73	$13.85	$13.57	$12.99	$12.76	$12.76	$12.81	$11.63
Total Capital	2,797	2,819	2,903	2,731	2,558	2,526	2,465	2,468	2,485	2,501	2,319
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	24	33	35	50	65
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	50
Net Debt	-1,131	-1,218	-1,216	-1,108	-871	-937	-797	-780	-824	-955	-822
Capital Expenditures (CapEx)	67	62	54	569	44	44	35	39	41	35	39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	599	592	692	669	762	682	766	778	777	667	664
Debt-free Net Working Capital (DFNWC)	1,107	1,192	1,244	1,130	1,511	1,502	1,482	1,487	1,519	1,562	1,440
Net Working Capital (NWC)	1,107	1,192	1,244	1,130	1,511	1,502	1,459	1,454	1,484	1,512	1,426
Net Nonoperating Expense (NNE)	7.15	2.07	-5.31	-7.67	4.29	-13	-0.27	-3.74	-3.63	-25	4.31
Net Nonoperating Obligations (NNO)	-1,131	-1,218	-1,216	-1,108	-898	-963	-797	-780	-824	-955	-822
Total Depreciation and Amortization (D&A)	30	27	31	30	28	28	28	27	28	2.18	28
Debt-free, Cash-free Net Working Capital to Revenue	20.61%	21.00%	25.29%	24.76%	28.67%	25.50%	27.97%	27.21%	25.75%	21.15%	20.08%
Debt-free Net Working Capital to Revenue	38.08%	42.26%	45.44%	41.79%	56.84%	56.13%	54.14%	51.97%	50.34%	49.50%	43.53%
Net Working Capital to Revenue	38.08%	42.26%	45.44%	41.79%	56.84%	56.13%	53.29%	50.83%	49.18%	47.91%	43.09%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.61	$0.92	$0.89	$1.18	$0.42	$0.76	$0.83	$0.78	$0.54	$1.11	$1.17
Adjusted Weighted Average Basic Shares Outstanding	161.50M	159.08M	163.00M	157.80M	153.05M	154.31M	153.76M	154.76M	155.90M	158.43M	156.36M
Adjusted Diluted Earnings per Share	$0.61	$0.89	$0.89	$1.14	$0.40	$0.72	$0.78	$0.73	$0.50	$1.04	$1.10
Adjusted Weighted Average Diluted Shares Outstanding	162.00M	163.31M	164.25M	163.47M	162.35M	164.30M	164.05M	164.75M	166.31M	169.73M	166.73M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	160.42M	161.72M	162.86M	163.18M	156.11M	153.08M	152.88M	154.01M	155.04M	156.05M	155.76M
Normalized Net Operating Profit after Tax (NOPAT)	119	153	145	180	72	109	134	122	82	145	189
Normalized NOPAT Margin	17.32%	20.28%	19.61%	24.70%	12.07%	16.27%	19.03%	17.77%	13.22%	19.80%	22.88%
Pre Tax Income Margin	17.36%	20.96%	21.56%	30.06%	12.15%	20.85%	20.50%	21.10%	15.72%	26.68%	27.35%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	144.33	260.67	191.48	140.01	99.39	162.46	143.69	133.10	94.04	190.00	289.68
NOPAT to Interest Expense	133.39	252.25	173.69	116.73	103.61	128.35	132.75	111.31	80.95	144.84	241.07
EBIT Less CapEx to Interest Expense	60.01	154.57	124.34	-232.21	32.79	107.79	107.75	95.54	52.05	155.93	239.70
NOPAT Less CapEx to Interest Expense	49.07	146.15	106.55	-255.49	37.01	73.68	96.82	73.74	38.96	110.78	191.10
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	13.42%	14.09%	14.37%	14.34%	16.09%	15.13%	13.53%	12.24%	10.83%	9.74%	8.97%
Augmented Payout Ratio	71.29%	50.70%	34.99%	54.63%	92.02%	103.65%	82.70%	92.17%	111.90%	114.86%	131.99%

Frequently Asked Questions About Teradyne's Financials

When does Teradyne's financial year end?

According to the most recent income statement we have on file, Teradyne's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Teradyne's net income changed over the last 9 years?

Teradyne's net income appears to be on an upward trend, with a most recent value of $542.37 million in 2024, rising from $206.48 million in 2015. The previous period was $448.75 million in 2023. See where experts think Teradyne is headed by visiting Teradyne's forecast page.

What is Teradyne's operating income?

Teradyne's total operating income in 2024 was $593.79 million, based on the following breakdown:

Total Gross Profit: $1.65 billion
Total Operating Expenses: $1.06 billion

How has Teradyne revenue changed over the last 9 years?

Over the last 9 years, Teradyne's total revenue changed from $1.64 billion in 2015 to $2.82 billion in 2024, a change of 72.0%.

How much debt does Teradyne have?

Teradyne's total liabilities were at $889.42 million at the end of 2024, a 7.4% decrease from 2023, and a 52.6% increase since 2015.

How much cash does Teradyne have?

In the past 9 years, Teradyne's cash and equivalents has ranged from $264.71 million in 2015 to $1.12 billion in 2021, and is currently $553.35 million as of their latest financial filing in 2024.

How has Teradyne's book value per share changed over the last 9 years?

Over the last 9 years, Teradyne's book value per share changed from 9.57 in 2015 to 17.31 in 2024, a change of 81.0%.

Related Companies

This page (NASDAQ:TER) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teradyne (TER) Financials

Frequently Asked Questions About Teradyne's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Teradyne (TER) Financials

Annual Income Statements for Teradyne

Quarterly Income Statements for Teradyne

Annual Cash Flow Statements for Teradyne

Quarterly Cash Flow Statements for Teradyne

Annual Balance Sheets for Teradyne

Quarterly Balance Sheets for Teradyne

Annual Metrics And Ratios for Teradyne

Quarterly Metrics And Ratios for Teradyne

Frequently Asked Questions About Teradyne's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools